US Stock MarketDetailed Quotes
FATE Fate Therapeutics
- 1.680
- +0.020+1.20%
Close Dec 20 16:00 ET
- 1.680
- +0.000+0.01%
Post 19:28 ET
191.34MMarket Cap-1.02P/E (TTM)
1.800High1.640Low10.14MVolume1.675Open1.660Pre Close17.11MTurnover10.23%Turnover RatioLossP/E (Static)113.89MShares8.83052wk High0.53P/B166.54MFloat Cap1.59052wk Low--Dividend TTM99.13MShs Float121.160Historical High--Div YieldTTM9.61%Amplitude1.460Historical Low1.688Avg Price1Lot Size
Fate Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 23.13%-29.42M | -13.38%-32.31M | -15.56%-33.35M | 46.71%-132.26M | 51.40%-36.64M | 30.47%-38.27M | 46.40%-28.49M | 55.33%-28.86M | -52.40%-248.21M | -7.25%-75.39M |
| Net income from continuing operations | -5.55%-47.68M | 27.16%-38.43M | -154.25%-48M | 42.88%-160.93M | 21.72%-44.12M | 45.94%-45.17M | 30.68%-52.76M | 71.26%-18.88M | -32.79%-281.72M | 17.86%-56.36M |
| Depreciation and amortization | -2.81%4.61M | 5.71%4.72M | 15.03%4.82M | 32.88%18.28M | 0.89%4.89M | 48.45%4.74M | 50.78%4.47M | 51.79%4.19M | 135.18%13.76M | 119.49%4.84M |
| Other non cash items | 100.70%13K | 59.15%-1.72M | 102.48%869K | -70.16%-40.86M | 102.32%220K | 51.58%-1.87M | -5,485.90%-4.2M | -225.31%-35.01M | -32.68%-24.01M | -41.76%-9.47M |
| Change In working capital | 210.88%3.13M | -127.00%-3.79M | -94.95%614K | 155.26%19.18M | 87.13%-4.19M | -127.86%-2.82M | 1,309.30%14.04M | 209.22%12.15M | -1,754.43%-34.71M | -152.99%-32.55M |
| -Change in receivables | -291.28%-2.48M | -101.30%-190K | -95.39%968K | 222.98%36.65M | 98.98%-288K | -55.36%1.3M | 1,925.69%14.67M | 505.49%20.98M | -843.16%-29.8M | -1,970.11%-28.26M |
| -Change in prepaid assets | 387.78%4.22M | -185.55%-3.49M | -61.64%4.57M | 170.25%12.88M | 77.91%-1.64M | 47.45%-1.47M | 171.15%4.08M | 594.43%11.9M | -500.59%-18.33M | -554.82%-7.41M |
| -Change in payables and accrued expense | 182.03%1.87M | 107.32%320K | 77.90%-4.51M | -303.06%-28.94M | -155.89%-1.89M | -122.19%-2.28M | -207.21%-4.37M | -483.82%-20.39M | 141.27%14.25M | 132.63%3.39M |
| -Change in other working capital | -29.38%-480K | -31.91%-434K | -22.62%-412K | -70.05%-1.41M | -37.27%-372K | -37.41%-371K | -40.00%-329K | -546.15%-336K | -134.46%-828K | -2,563.64%-271K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 23.13%-29.42M | -13.38%-32.31M | -15.56%-33.35M | 46.71%-132.26M | 51.40%-36.64M | 30.47%-38.27M | 46.40%-28.49M | 55.33%-28.86M | -52.40%-248.21M | -7.25%-75.39M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 2.64%25.46M | -260.92%-53.37M | 85.37%17.31M | -32.44%112.67M | -14.61%45.35M | -69.14%24.81M | -17.67%33.17M | 232.93%9.34M | 151.46%166.75M | -25.49%53.11M |
| Net PPE purchase and sale | 12.39%-495K | 97.68%-51K | 97.32%-86K | 82.70%-6.15M | 97.29%-181K | 93.49%-565K | 78.29%-2.2M | 68.19%-3.21M | 29.86%-35.57M | 63.65%-6.68M |
| Net investment purchase and sale | 2.31%25.96M | -250.77%-53.32M | 38.67%17.4M | -41.27%118.82M | -23.84%45.53M | -71.51%25.37M | -29.85%35.37M | 310.33%12.55M | 174.02%202.32M | -33.31%59.79M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 2.64%25.46M | -260.92%-53.37M | 85.37%17.31M | -32.44%112.67M | -14.61%45.35M | -69.14%24.81M | -17.67%33.17M | 232.93%9.34M | 151.46%166.75M | -25.49%53.11M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 2,096.55%1.27M | 46,029.47%95.49M | -99.08%85K | -111.87%-180K | 0 | -98.30%58K | -92.60%207K | -97.97%9.21M | -55.62%1.52M |
| Net common stock issuance | --0 | ---662K | --75.19M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | -106.90%-4K | 9,704.35%20.3M | -99.08%85K | -111.87%-180K | --0 | -98.30%58K | -92.60%207K | -77.76%9.21M | -56.02%1.52M |
| Net other financing activities | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 2,096.55%1.27M | 46,029.47%95.49M | -99.08%85K | -111.87%-180K | --0 | -98.30%58K | -92.60%207K | -97.97%9.21M | -55.62%1.52M |
| Net cash flow | ||||||||||
| Beginning cash position | -15.95%52.09M | 138.44%136.5M | -25.49%57.05M | -48.55%76.56M | -50.15%48.51M | -12.09%61.98M | -28.41%57.25M | -48.55%76.56M | -18.49%148.81M | -32.61%97.32M |
| Current changes in cash | 70.61%-3.96M | -1,883.71%-84.41M | 511.39%79.45M | 72.99%-19.51M | 141.12%8.54M | -150.22%-13.47M | 149.99%4.73M | 71.95%-19.31M | -113.99%-72.25M | -571.50%-20.76M |
| End cash Position | -0.77%48.14M | -15.95%52.09M | 138.44%136.5M | -25.49%57.05M | -25.49%57.05M | -50.15%48.51M | -12.09%61.98M | -28.41%57.25M | -48.55%76.56M | -48.55%76.56M |
| Free cash flow | 22.98%-29.91M | -5.42%-32.36M | -4.27%-33.44M | 51.22%-138.42M | 55.14%-36.82M | 39.05%-38.84M | 51.50%-30.69M | 57.07%-32.07M | -32.87%-283.77M | 7.44%-82.07M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data